Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 6 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer

Article in Biomedicines (July 2023)

A Cross-Protective Vaccine Against 4b and 1/2b Listeria monocytogenes

Article in Frontiers in Microbiology (December 2020)

Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy

Article in Cancers (September 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.